Product Information
ACITRETIN 10 MG CAPSULE is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $2.3225 per EA under NDC 00378702093. Its NADAC has been published 537 times since May 11, 2016.
FDA first approved this application on Sep 10, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The Low Outlier badge above means this manufacturer's average price in the acitretin market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
10 mg/1
Manufacturer
Mylan Pharmaceuticals Inc.NDC
00378702093
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
ACITRETINApproval Type
Generic (ANDA)
FDA Application
ANDA202148FDA Approved
9/10/2015
TE Code
AB
On Market Since
3/10/2016
Pharmacological Classes
Price Statistics
The NADAC for ACITRETIN 10 MG CAPSULE has been published 537 times since May 11, 2016, and over the history we have for it it has declined 89.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.3225 per EA |
|---|---|
| All-time high | $21.7584 (May 11, 2016) |
| All-time low | $2.1155 (May 20, 2026) |
| 52-week high | $4.4078 |
| 52-week low | $2.1155 |
| Median price | $7.4623 |
| Average price | $8.7677 |
| Largest weekly change | +103.6% (Mar 18, 2020) |
| Weeks tracked | 537 |
| Tracking since | May 11, 2016 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the acitretin market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ACITRETIN 10 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for ACITRETIN 10 MG CAPSULE, manufactured by Mylan Pharmaceuticals Inc., is $2.3225 per EA (NDC 00378702093), effective Aug 19, 2026.
How has the price of ACITRETIN 10 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for ACITRETIN 10 MG CAPSULE has declined 89.3%. It has been tracked across 537 weekly CMS publications since May 11, 2016.
What are the highest and lowest recorded NADAC prices for ACITRETIN 10 MG CAPSULE?
Since May 11, 2016, the NADAC for ACITRETIN 10 MG CAPSULE has ranged from a low of $2.1155 (May 20, 2026) to a high of $21.7584 (May 11, 2016), with a median of $7.4623 per EA.
Are there cheaper alternatives to ACITRETIN 10 MG CAPSULE?
No other NADAC-published product currently shares the active ingredient and strength of ACITRETIN 10 MG CAPSULE in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures ACITRETIN 10 MG CAPSULE?
ACITRETIN 10 MG CAPSULE (NDC 00378702093) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.